Skip to main navigation Skip to search Skip to main content

Differential crizotinib response duration among ALK fusion variants in ALK-positive non-small-cell lung cancer

  • Tatsuya Yoshida
  • , Yuko Oya
  • , Kosuke Tanaka
  • , Junichi Shimizu
  • , Yoshitsugu Horio
  • , Hiroaki Kuroda
  • , Yukinori Sakao
  • , Toyoaki Hida
  • , Yasushi Yatabe

Research output: Contribution to journal › Article › peer-review

249   Link opens in a new tab Citations (Scopus)

Fingerprint

Dive into the research topics of 'Differential crizotinib response duration among ALK fusion variants in ALK-positive non-small-cell lung cancer'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases